Ghost Tree Capital, LLC Orchard Therapeutics PLC Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$5.75 - $11.99 $1.02 Million - $2.14 Million	-178,109 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.65 - $15.71 $261,312 - $726,587	-46,250 Reduced 20.61%	178,109 $1.34 Million
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $188,698 - $289,647	-18,591 Reduced 7.65%	224,359 $3.09 Million
Q2 2019 Aug 14, 2019	SELL	$13.2 - $20.63 $753,060 - $1.18 Million	-57,050 Reduced 19.02%	242,950 $3.4 Million
Q4 2018 Feb 14, 2019	BUY	$12.4 - $18.7 $3.72 Million - $5.61 Million	300,000 New	300,000 $4.72 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.